Changes of Blood Endocannabinoids During Anaesthesia: a Special Case for Fatty Acid Amide Hydrolase Inhibition by Propofol?

Overview

Journal Br J Clin Pharmacol

Specialty Pharmacology

Date 2012 Jan 17

PMID 22242687

Citations 6

Authors

Carina Jarzimski

Matthias Karst

Alexander A Zoerner

Christin Rakers

Marcus May

Maria T Suchy

Dimitrios Tsikas

Joachim K Krauss

Dirk Scheinichen

Jens Jordan

Stefan Engeli

Affiliations

Soon will be listed here.

Abstract

What Is Already Known About This Subject: • Available data from animal studies suggest that the narcotic drug propofol interacts with the endocannabinoid system. Inhibition of enzymatic degradation of anandamide could explain some of the characteristics of propofol. Direct measurements have not been reported yet in humans.

What This Study Adds: • Propofol does not change the time course of anandamide plasma concentrations during anaesthesia. Furthermore, propofol does not inhibit fatty acid amide hydrolase activity ex vivo or in vitro. Thus, specific characteristics of the narcotic drug propofol cannot be explained by peripheral inhibition of anandamide degradation in humans.

Aims: The aim of our study was to describe the time course of endocannabinoids during different anaesthesia protocols in more detail, and to challenge the hypothesis that propofol acts as a FAAH inhibitor.

Methods: Endocannabinoids were measured during the first hour of anaesthesia in 14 women and 14 men undergoing general anaesthesia with propofol and in 14 women and 14 men receiving thiopental/sevoflurane. We also incubated whole human blood samples ex vivo with propofol and the known FAAH inhibitor oloxa and determined FAAH enzyme kinetics.

Results: Plasma anandamide decreased similarly with propofol and thiopental/sevoflurane anaesthesia, and reached a nadir after 10 min. Areas under the curve for anandamide (mean and 95% CI) were 53.3 (47.4, 59.2) nmol l(-1) 60 min with propofol and 48.5 (43.1, 53.8) nmol l(-1) 60 min with thiopental/sevoflurane (P= NS). Anandamide and propofol plasma concentrations were not correlated at any time point. Ex vivo FAAH activity was not inhibited by propofol. Enzyme kinetics (mean ± SD) of recombinant human FAAH were K(m) = 16.9 ± 8.8 µmol l(-1) and V(max) = 44.6 ± 15.8 nmol mg(-1) min(-1) FAAH without, and K(m) = 16.6 ± 4.0 µmol l(-1) and V(max) = 44.0 ± 7.6 nmol mg( 1 ) min(-1) FAAH with 50 µmol l(-1) propofol (P= NS for both).

Conclusions: Our findings challenge the idea that propofol anaesthesia and also propofol addiction are directly mediated by FAAH inhibition, but we cannot exclude other indirect actions on cannabinoid receptors.

Citing Articles

The Basic Science of Cannabinoids.

Sideris A, Lauzadis J, Kaczocha M Anesth Analg. 2023; 138(1):42-53.

PMID: 38100799 PMC: 10788142. DOI: 10.1213/ANE.0000000000006472.

Intrathecal morphine administration reduces postoperative pain and peripheral endocannabinoid levels in total knee arthroplasty patients: a randomized clinical trial.

Kaczocha M, Azim S, Nicholson J, Rebecchi M, Lu Y, Feng T BMC Anesthesiol. 2018; 18(1):27.

PMID: 29486720 PMC: 6389072. DOI: 10.1186/s12871-018-0489-5.

Activation of Endocannabinoid Receptor 2 as a Mechanism of Propofol Pretreatment-Induced Cardioprotection against Ischemia-Reperfusion Injury in Rats.

Sun H, Lu Y, Wang H, Zhang H, Wang S, Xu W Oxid Med Cell Longev. 2017; 2017:2186383.

PMID: 28814985 PMC: 5549482. DOI: 10.1155/2017/2186383.

Circulating Endocannabinoids: From Whence Do They Come and Where are They Going?.

Hillard C Neuropsychopharmacology. 2017; 43(1):155-172.

PMID: 28653665 PMC: 5719092. DOI: 10.1038/npp.2017.130.

Blood pressure-lowering effects of propofol or sevoflurane anaesthesia are not due to enhanced nitric oxide formation or bioavailability.

Tsikas D, Jordan J, Engeli S Br J Clin Pharmacol. 2014; 79(6):1030-3.

PMID: 25475891 PMC: 4456136. DOI: 10.1111/bcp.12568.

References

Wilson C, Canning P, Caravati E . The abuse potential of propofol. Clin Toxicol (Phila). 2010; 48(3):165-70. DOI: 10.3109/15563651003757954. View

Vogeser M, Hauer D, Azad S, Huber E, Storr M, Schelling G . Release of anandamide from blood cells. Clin Chem Lab Med. 2006; 44(4):488-91. DOI: 10.1515/CCLM.2006.065. View

Weis F, Beiras-Fernandez A, Hauer D, Hornuss C, Sodian R, Kreth S . Effect of anaesthesia and cardiopulmonary bypass on blood endocannabinoid concentrations during cardiac surgery. Br J Anaesth. 2010; 105(2):139-44. DOI: 10.1093/bja/aeq117. View

Hauer D, Ratano P, Morena M, Scaccianoce S, Briegel I, Palmery M . Propofol enhances memory formation via an interaction with the endocannabinoid system. Anesthesiology. 2011; 114(6):1380-8. DOI: 10.1097/ALN.0b013e31821c120e. View

Guindon J, Loverme J, Piomelli D, Beaulieu P . The antinociceptive effects of local injections of propofol in rats are mediated in part by cannabinoid CB1 and CB2 receptors. Anesth Analg. 2007; 104(6):1563-9, table of contents. DOI: 10.1213/01.ane.0000263278.05423.a3. View

Hill M, McEwen B . Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids. Prog Neuropsychopharmacol Biol Psychiatry. 2009; 34(5):791-7. PMC: 2945244. DOI: 10.1016/j.pnpbp.2009.11.001. View

Kathuria S, Gaetani S, Fegley D, Valino F, Duranti A, Tontini A . Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med. 2002; 9(1):76-81. DOI: 10.1038/nm803. View

Schelling G, Hauer D, Azad S, Schmoelz M, Chouker A, Schmidt M . Effects of general anesthesia on anandamide blood levels in humans. Anesthesiology. 2006; 104(2):273-7. DOI: 10.1097/00000542-200602000-00012. View

Patel S, Wohlfeil E, Rademacher D, Carrier E, Perry L, Kundu A . The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase. Br J Pharmacol. 2003; 139(5):1005-13. PMC: 1573928. DOI: 10.1038/sj.bjp.0705334. View

10.

Sipe J, Chiang K, Gerber A, Beutler E, Cravatt B . A missense mutation in human fatty acid amide hydrolase associated with problem drug use. Proc Natl Acad Sci U S A. 2002; 99(12):8394-9. PMC: 123078. DOI: 10.1073/pnas.082235799. View

11.

Pernia-Andrade A, Kato A, Witschi R, Nyilas R, Katona I, Freund T . Spinal endocannabinoids and CB1 receptors mediate C-fiber-induced heterosynaptic pain sensitization. Science. 2009; 325(5941):760-4. PMC: 2835775. DOI: 10.1126/science.1171870. View

12.

Vaughn L, Denning G, Stuhr K, de Wit H, Hill M, Hillard C . Endocannabinoid signalling: has it got rhythm?. Br J Pharmacol. 2010; 160(3):530-43. PMC: 2931554. DOI: 10.1111/j.1476-5381.2010.00790.x. View

13.

Zoerner A, Gutzki F, Suchy M, Beckmann B, Engeli S, Jordan J . Targeted stable-isotope dilution GC-MS/MS analysis of the endocannabinoid anandamide and other fatty acid ethanol amides in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2009; 877(26):2909-23. DOI: 10.1016/j.jchromb.2009.04.016. View

14.

Karst M, Wippermann S, Ahrens J . Role of cannabinoids in the treatment of pain and (painful) spasticity. Drugs. 2010; 70(18):2409-38. DOI: 10.2165/11585260-000000000-00000. View

15.

Pacher P, Batkai S, Kunos G . The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev. 2006; 58(3):389-462. PMC: 2241751. DOI: 10.1124/pr.58.3.2. View

16.

Boger D, Sato H, Lerner A, Hedrick M, Fecik R, Miyauchi H . Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide. Proc Natl Acad Sci U S A. 2000; 97(10):5044-9. PMC: 25778. DOI: 10.1073/pnas.97.10.5044. View

17.

Chouker A, Kaufmann I, Kreth S, Hauer D, Feuerecker M, Thieme D . Motion sickness, stress and the endocannabinoid system. PLoS One. 2010; 5(5):e10752. PMC: 2873996. DOI: 10.1371/journal.pone.0010752. View

18.

Blednov Y, Cravatt B, Boehm 2nd S, Walker D, Harris R . Role of endocannabinoids in alcohol consumption and intoxication: studies of mice lacking fatty acid amide hydrolase. Neuropsychopharmacology. 2006; 32(7):1570-82. DOI: 10.1038/sj.npp.1301274. View

19.

Iwakiri H, Nishihara N, Nagata O, Matsukawa T, Ozaki M, Sessler D . Individual effect-site concentrations of propofol are similar at loss of consciousness and at awakening. Anesth Analg. 2004; 100(1):107-110. PMC: 1343509. DOI: 10.1213/01.ANE.0000139358.15909.EA. View

20.

Agarwal N, Pacher P, Tegeder I, Amaya F, Constantin C, Brenner G . Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nat Neurosci. 2007; 10(7):870-9. PMC: 2234438. DOI: 10.1038/nn1916. View